logoslogan

ADJUVANT TREATMENTS

Does anything work? Evidence lacking in every add-on newly analysed

Once again, adjuvant treatments to improve the chance of live birth are under the spotlight. New reviews of more than 20 clinical, endometrial and laboratory add-ons find no persuasive evidence for their application in everyday practice.

GENOME EDITING

Chinese CRISPR-Cas9 baby scientist jailed

An official China news agency reports that the biophysicist behind the birth of gene edited twins in 2018 has been found guilty of violating research regulations.

CAMPUS: EGG DONATION

Biological or donor parenthood in the treatment of infertility

A Campus meeting in November reviewed the arguments for and against donor conception, and the sometimes difficult ethical arguments raised by the prospect of a donor-conceived child. About the latter, opinion now seems universally in favour of early disclosure of biological origins.

GUIDELINES OVARIAN STIMULATION

Moving towards agreement in ovarian stimulation

A well attended Campus meeting in October reviewed themes of debate in ovarian stimulation following publication of ESHRE's new guidelines. Not all were simple matters of consensus, especially in those areas where evidence was thin or 'conditional'.

OPEN ACCESS

Subscription journals braced for open access

An ESHRE expert meeting in November reviewed what we know so far about open access publishing for medical journals. The meeting in particular explored where we now are with Plan S and how its implementation might affect the Human Reproduction journals.

Access to treatment

ACCESS TO TREATMENT

Inequalities in global access to fertility care

A Campus meeting in December reviewed the wide variety of cultural, ethical and economic barriers preventing equal access to fertility treatment.

LEGISLATION GERMANY

Germany: embryo protection laws need overhaul, says national academy

Germany's National Academy of Science, Leopoldina, has issued a new proposal to update ART legislation in line with social changes and technical developments. Included in the proposals are egg donation and embryo selection. Meanwhile, legislation in France is about to change.

ACCESS TO TREATMENT

Improving global access to fertility care

A Campus meeting in December concluded that global access to effective fertility can be achieved, but only with the combined commitments of fertility education, affordable treatment, and the support of governments.

CAMPUS: EGG DONATION

Artificial sperm cells to remove the genetic worries of sperm donation

A Campus meeting in November reviewed the arguments for and against donor conception, and the sometimes difficult ethical arguments raised by the prospect of a donor-conceived child. 'Artificial' sperm cells derived from testicular tissue or stem cells may resolve some of those arguments.

SPANISH REGISTRY DATA

Spain continues to set pace in European ART

Total cycles increase by only 2%, with the majority of transfers derived from frozen embryos. Egg donation represents around one-third of all activity and around half of all cross-border treatments.